Trientine Tetrahydrochloride

四盐酸曲恩汀

Report date: 2026/05/02 20:00:18

Base Information

Drug NameTrientine Tetrahydrochloride
Drug Alias NameCUVRIORCuvrior科佩欧CupriorTETA-4HCl
ClassificationSmall molecules
Mechanisms of ActionCopper chelating agents
TargetsCopper
Therapy Area/IndicationsHepatolenticular Degeneration
Global Approved IndicationsHepatolenticular Degeneration
Approved Indications in ChinaHepatolenticular Degeneration
Original Approved Country/TerritoryUnited States
Original Approved Date2022/04/28
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOrphalan SA
China Registration ClassN/A

Develop Information

Active CompaniesOrphalan SA
Inactive CompaniesDelpharm Evreux SAS
Active IndicationsHepatolenticular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeA16AX12
Related LinksDrugBankKEGG